Cited by 160Fatty Acid Research and HealthNutritional Studies and DietAquaculture Nutrition and Growth

Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease

Open access
Nestel, Paul, Clifton, Peter, Colquhoun, David, Noakes, Manny, Mori, Trevor A., Sullivan, David, Thomas, Beth·2015·Heart, Lung and Circulation

Abstract

Background The National Heart Foundation of Australia (NHFA) 2008 review on omega-3 long-chain polyunsaturated fatty acids (LCPUFA) made recommendations with respect to supplementation for primary and secondary prevention of cardiovascular disease. Since then, new findings have been published regarding the relationship between omega-3 polyunsaturated fatty acids, including supplementation, and cardiovascular health.Methods A literature search was undertaken in PubMed and Medline, for literature published between January 1, 2007 and August 31, 2013.Results and conclusions A total of eight research questions were developed and, using the National Health and Medical Research Council's evidence assessment framework, conclusions were made in relation to dietary intake of fish and omega-3 LCPUFA for cardiovascular health. In the evidence published since 2007, this summary of evidence concludes that dietary intake of fish was found to be mostly consistent with respect to protection from heart disease and stroke. Higher fish intake was associated with lower incident rates of heart failure in addition to lower sudden cardiac death, stroke and myocardial infarction. In relation to omega-3 LCPUFA supplementation, neither a beneficial nor adverse effect was demonstrated in primary or secondary prevention of coronary heart disease (CHD). Although the evidence continues to be positive for the role of omega-3 LCPUFA in the treatment of hypertriglyceridaemia and a modest positive benefit in heart failure. No further evidence was found to support the consumption of 2g alpha-linolenic acid (ALA)/day over the current Australian guidelines for 1 g/day.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.hlc.2015.03.020

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo- controlled trial. Lancet 2008;372(9645):1223-30.

Cited by

Sorted by citations

Authors
Nestel, P., Clifton, P., Colquhoun, D., Noakes, M., Mori, T. A., Sullivan, D., & Thomas, B.
Affiliations
  • Baker Heart and Diabetes Institute (AU)
  • University of South Australia (AU)
  • The University of Queensland (AU)
  • Commonwealth Scientific and Industrial Research Organisation (AU)
  • The University of Western Australia (AU)
  • The University of Sydney (AU)
  • National Heart Foundation of Australia (AU)
Corresponding author
Nestel, Paul
Venue
Heart, Lung and Circulation
Publisher
Elsevier BV
Published
2015-08
Volume
24
Issue
8
Pages
769-779
ISSN
1443-9506 (ISSN-L)
OpenAlex
W2094823376
Cited by
160
References
99
Citations by year
2026: 1 · 2025: 6 · 2024: 9 · 2023: 11 · 2022: 12 · 2021: 9 · 2020: 11 · 2019: 18 · 2018: 22 · 2017: 26 · 2016: 22 · 2015: 13
FWCI
3.56
Type
journal article
Language
en
Open access
Locations
  • Heart Lung and Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Funders
National Heart Foundation of Australia
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
Keywords
n-3 long-chain polyunsaturated fatty acids, fish consumption, omega-3 supplementation, cardiovascular disease prevention, coronary artery disease, heart failure, sudden cardiac death, stroke, myocardial infarction, hypertriglyceridemia, alpha-linolenic acid, dietary recommendations
MeSH terms
Animals, Cardiovascular Diseases, Humans, Fatty Acids, Omega-3, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review